Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors as of Dec. 31, 2023

Portfolio Holdings for Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors holds 16 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kymera Therapeutics Common Stock (KYMR) 17.8 $149M 5.9M 25.46
Disc Medicine Common Stock (IRON) 17.6 $148M 2.6M 57.76
Dyne Therapeutics Common Stock (DYN) 15.7 $132M 9.9M 13.30
Third Harmonic Bio Common Stock (THRD) 14.2 $120M 11M 10.97
Day One Biopharmaceuticals Common Stock (DAWN) 13.2 $111M 7.6M 14.60
Korro Bio Common Stock (KRRO) 6.4 $54M 1.1M 47.93
Aerovate Therapeutics Common Stock (AVTE) 5.5 $46M 2.0M 22.63
Vigil Neuroscience Common Stock (VIGL) 2.3 $20M 5.8M 3.38
Replimune Group Common Stock (REPL) 2.1 $18M 2.1M 8.43
Generation Bio Common Stock (GBIO) 1.6 $14M 8.3M 1.65
Ikena Oncology Common Stock (IKNA) 1.2 $9.9M 5.0M 1.97
Akero Therapeutics Common Stock (AKRO) 1.0 $8.4M 359k 23.35
AvroBio Common Stock (AVRO) 0.7 $6.2M 4.5M 1.36
Dianthus Therapeutics Common Stock (DNTH) 0.3 $2.5M 237k 10.40
Xilio Therapeutics Common Stock (XLO) 0.2 $1.5M 2.8M 0.55
Spero Therapeutics Common Stock (SPRO) 0.2 $1.5M 1.0M 1.47